.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Check market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

BARACLUDE Drug Profile

« Back to Dashboard
Baraclude is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from two suppliers.

The generic ingredient in BARACLUDE is entecavir. There are fifteen drug master file entries for this compound. Ten suppliers are listed for this compound. Additional details are available on the entecavir profile page.

Summary for Tradename: BARACLUDE

Patents:0
Applicants:1
NDAs:2
Suppliers / Packagers: see list2
Bulk Api Vendors: see list65
Clinical Trials: see list15
Patent Applications: see list1,560
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BARACLUDE at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-001Mar 29, 2005RXYesNo► subscribe► subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-002Mar 29, 2005RXYesYes► subscribe► subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-001Mar 29, 2005RXYesNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BARACLUDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-002Mar 29, 20055,206,244*PED► subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
TABLET;ORAL021797-001Mar 29, 20055,206,244*PED► subscribe
Bristol Myers Squibb
BARACLUDE
entecavir
SOLUTION;ORAL021798-001Mar 29, 20055,206,244*PED► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: BARACLUDE

Drugname Dosage Strength RLD Submissiondate
entecavirTablets0.5 mg and 1 mgBaraclude6/14/2010
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc